Levetiracetam
Material: | 1 ml serum |
Methods: |
Flüssigkeitschromatographie-Massenspektrometrie (LC-MS/MS) → LC-Tandem-Massenspektrometrie Ligandenassays → Enzym-Multiplied-Immunoassay (EMIT) |
Indication | Therapeutic drug monitoring |
Therapeutic range | 10 mg/l – 40 mg/l |
Please note | The effect mechanism of levetiracetam is still unknown. Known side effects are somnolence, asthenia, nausea, headaches, depression, diarrhea, vertigo and exanthema. In case of concurrent administration of bivaracetam, there may be cross-reactions in the immuneoassay. In this case, the request should be for “Levetiracetam – chromatographically, LC-MS/MS”. |
Accredited | ja |
More Results for the letter L
- Lacosamide (LACO)
- Lacrimal gland, autoantibodies to (LACR)
- Lactate in blood (plasma), CSF or synovial fluid (LACT)
- Lactic acid
- Lactoferrin (LACTST)
- also known as lactotransferrin
- Lactose in breast milk (LAKTUMU)
- Lactose in urine (LAKTU)
- Lactose intolerance (LACPCR)
- Genetic testing T13910C, genetic testing for lactose intolerance
- Lamblia (EGIAR, MGIAR)
- Giardia lamblia
- Laminin autoantibodies (LAMIN)
- Lamotrigine (LAMO)
- LAP (LAP)
- Leucine aminopeptidase, leucine arylamidase
- Lassa virus infection (LASSA)
- Laxatives (LAXA)
- LBP (LBP)
- Lipopolysaccharide binding protein
- LC1 autoantibodies (LC1)
- Formiminotransferase cyclodeaminase (FTCD)
- LCM virus (LCMK)
- Lymphocytic choriomeningitis
- LDH (LDH)
- Lactate dehydrogenase
- LDH isoenzymes (LDHISO)
- Lactate dehydrogenase isoenzymes
- LDL cholesterol (LDL)
- Low-density lipoprotein cholesterol
- Lead in the blood (BLEI)
- Pb
- Lead in the urine (BLU)
- Pb
- Legionella (KLEGI)
- Legionella pneumophila
- Leishmaniasis (LEISH)
- Leptin (LEPTI)
- Leptospirosis (LEPGA)
- Leptospira interrogans
- Levetiracetam (LEVET)
- Levomepromazine (LEVO)
- LH (LH)
- Luteinizing hormone
- Lindan (LINDAN)
- Gamma-hexachlorcyclohexane
- Lipase (LIP)
- Pancreatic lipase